Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer

BJU International

Volumn 112, Issue 3, 2013, Pages 322-329

  Ganzer, Roman ^a   Fritsche, Hans Martin ^a   Brandtner, Andreas ^a   Bründl, Johannes ^a   Koch, Daniel ^b   Wieland, Wolf F ^a   Blana, Andreas ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Hospital Fuerth   (Germany)

Author keywords

HIFU; localized; long term; outcome; prostate cancer

Indexed keywords

AGED; ARTICLE; BLADDER NECK STENOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SPECIFIC SURVIVAL; CLINICAL EFFECTIVENESS; DISEASE FREE SURVIVAL; FOLLOW UP; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; METASTASIS; METASTASIS FREE SURVIVAL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; SAFETY; SALVAGE THERAPY; STRESS INCONTINENCE;

HIFU; LOCALIZED; LONG-TERM; OUTCOME; PROSTATE CANCER;

AGED; HUMANS; MALE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 84879886396     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11715.x     Document Type: Article

References (20)

1. Blana A, Murat FJ, Walter B, et al. First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. Eur Urol 2008; 53: 1194-1201
2. Crouzet S, Rebillard X, Chevallier D, et al. Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients. Eur Urol 2010; 58: 559-566
3. Poissonnier L, Chapelon JY, Rouviere O, et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 2007; 51: 381-387
4. Uchida T, Ohkusa H, Yamashita H, et al. Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Int J Urol 2006; 13: 228-233
5. Warmuth M, Johansson T, Mad P,. Systematic review of the efficacy and safety of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer. Eur Urol 2010; 58: 803-815
6. D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH,. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 2003; 21: 2163-2172
7. Roach M III, Hanks G, Thames H Jr, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006; 65: 965-974
8. Rebillard X, Soulie M, Chartier-Kastler E, et al. High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology. BJU Int 2008; 101: 1205-1213
9. Heidenreich A, Aus G, Bolla M, et al. EAU guidelines on prostate cancer. Actas Urol Esp 2009; 33: 113-126
10. Ganzer R, Rogenhofer S, Walter B, et al. PSA nadir is a significant predictor of treatment failure after High-Intensity Focussed Ultrasound (HIFU) treatment of localised prostate cancer. Eur Urol 2008; 53: 547-553
11. Blana A, Brown SC, Chaussy C, et al. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure. BJU Int 2009; 104: 1058-1062
12. Abdel-Wahab M, Pollack A,. Prostate cancer: defining biochemical failure in patients treated with HIFU. Nat Rev Urol 2010; 7: 186-187
13. Fujisue Y, Azuma H, Inamoto T, et al. Neoadjuvant hormonal therapy does not impact the treatment success of high-intensity focused ultrasound for the treatment of localized prostate cancer. World J Urol 2011; 29: 689-694
14. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011; 364: 1708-1717
15. Zelefsky MJ, Eastham JA, Cronin AM, et al. Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. J Clin Oncol 2010; 28: 1508-1513
16. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M,. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002; 60: 3-11
17. Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR,. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer 2008; 112: 307-314
18. Shoji S, Nakano M, Nagata Y, Usui Y, Terachi T, Uchida T,. Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: a prospective study. Int J Urol 2010; 17: 715-719
19. Blana A, Hierl J, Rogenhofer S, et al. Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer. Urology 2008; 71: 863-867
20. Netsch C, Pfeiffer D, Gross AJ,. Development of bladder outlet obstruction after a single treatment of prostate cancer with high-intensity focused ultrasound: experience with 226 patients. J Endourol 2010; 24: 1399-1403